| Product Code: ETC6130923 | Publication Date: Sep 2024 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
In the Argentina apremilast market, import trends showed a decline with a growth rate of -18.13% from 2023 to 2024. However, the compound annual growth rate (CAGR) for imports between 2020 and 2024 stood at 5.88%. This downward import momentum in 2024 could be attributed to shifting demand patterns or changes in trade policies impacting market stability.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Argentina Apremilast Market Overview |
3.1 Argentina Country Macro Economic Indicators |
3.2 Argentina Apremilast Market Revenues & Volume, 2021 & 2031F |
3.3 Argentina Apremilast Market - Industry Life Cycle |
3.4 Argentina Apremilast Market - Porter's Five Forces |
3.5 Argentina Apremilast Market Revenues & Volume Share, By Strength, 2021 & 2031F |
3.6 Argentina Apremilast Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.7 Argentina Apremilast Market Revenues & Volume Share, By Demographic, 2021 & 2031F |
3.8 Argentina Apremilast Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.9 Argentina Apremilast Market Revenues & Volume Share, By Dosage Form, 2021 & 2031F |
3.10 Argentina Apremilast Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.11 Argentina Apremilast Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
4 Argentina Apremilast Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of psoriasis and psoriatic arthritis in Argentina |
4.2.2 Growing awareness and acceptance of apremilast as a treatment option |
4.2.3 Favorable government regulations and policies supporting the use of apremilast |
4.3 Market Restraints |
4.3.1 High cost associated with apremilast treatment |
4.3.2 Limited availability of healthcare facilities offering apremilast therapy |
4.3.3 Potential side effects and safety concerns related to apremilast usage |
5 Argentina Apremilast Market Trends |
6 Argentina Apremilast Market, By Types |
6.1 Argentina Apremilast Market, By Strength |
6.1.1 Overview and Analysis |
6.1.2 Argentina Apremilast Market Revenues & Volume, By Strength, 2021- 2031F |
6.1.3 Argentina Apremilast Market Revenues & Volume, By 10mg, 2021- 2031F |
6.1.4 Argentina Apremilast Market Revenues & Volume, By 20mg, 2021- 2031F |
6.1.5 Argentina Apremilast Market Revenues & Volume, By 30mg, 2021- 2031F |
6.2 Argentina Apremilast Market, By Drug Class |
6.2.1 Overview and Analysis |
6.2.2 Argentina Apremilast Market Revenues & Volume, By Antirheumatics, 2021- 2031F |
6.2.3 Argentina Apremilast Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Argentina Apremilast Market, By Demographic |
6.3.1 Overview and Analysis |
6.3.2 Argentina Apremilast Market Revenues & Volume, By Adult, 2021- 2031F |
6.3.3 Argentina Apremilast Market Revenues & Volume, By Pediatric, 2021- 2031F |
6.4 Argentina Apremilast Market, By Application |
6.4.1 Overview and Analysis |
6.4.2 Argentina Apremilast Market Revenues & Volume, By Psoriasis, 2021- 2031F |
6.4.3 Argentina Apremilast Market Revenues & Volume, By Psoriatic Arthritis, 2021- 2031F |
6.4.4 Argentina Apremilast Market Revenues & Volume, By Others, 2021- 2031F |
6.5 Argentina Apremilast Market, By Dosage Form |
6.5.1 Overview and Analysis |
6.5.2 Argentina Apremilast Market Revenues & Volume, By Tablet, 2021- 2031F |
6.5.3 Argentina Apremilast Market Revenues & Volume, By Others, 2021- 2031F |
6.6 Argentina Apremilast Market, By Route of Administration |
6.6.1 Overview and Analysis |
6.6.2 Argentina Apremilast Market Revenues & Volume, By Oral, 2021- 2031F |
6.6.3 Argentina Apremilast Market Revenues & Volume, By Others, 2021- 2031F |
6.7 Argentina Apremilast Market, By End-Users |
6.7.1 Overview and Analysis |
6.7.2 Argentina Apremilast Market Revenues & Volume, By Clinic, 2021- 2031F |
6.7.3 Argentina Apremilast Market Revenues & Volume, By Hospital, 2021- 2031F |
6.7.4 Argentina Apremilast Market Revenues & Volume, By , 2021- 2031F |
6.8 Argentina Apremilast Market, By Distribution Channel |
6.8.1 Overview and Analysis |
6.8.2 Argentina Apremilast Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.8.3 Argentina Apremilast Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.8.4 Argentina Apremilast Market Revenues & Volume, By , 2021- 2031F |
7 Argentina Apremilast Market Import-Export Trade Statistics |
7.1 Argentina Apremilast Market Export to Major Countries |
7.2 Argentina Apremilast Market Imports from Major Countries |
8 Argentina Apremilast Market Key Performance Indicators |
8.1 Patient adherence rate to apremilast treatment |
8.2 Number of healthcare professionals trained in prescribing apremilast |
8.3 Rate of insurance coverage for apremilast therapy |
9 Argentina Apremilast Market - Opportunity Assessment |
9.1 Argentina Apremilast Market Opportunity Assessment, By Strength, 2021 & 2031F |
9.2 Argentina Apremilast Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.3 Argentina Apremilast Market Opportunity Assessment, By Demographic, 2021 & 2031F |
9.4 Argentina Apremilast Market Opportunity Assessment, By Application, 2021 & 2031F |
9.5 Argentina Apremilast Market Opportunity Assessment, By Dosage Form, 2021 & 2031F |
9.6 Argentina Apremilast Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.7 Argentina Apremilast Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.7 Argentina Apremilast Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Argentina Apremilast Market - Competitive Landscape |
10.1 Argentina Apremilast Market Revenue Share, By Companies, 2024 |
10.2 Argentina Apremilast Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here